PUBLISHER: Grand View Research | PRODUCT CODE: 1493471
PUBLISHER: Grand View Research | PRODUCT CODE: 1493471
The global iodine market size is expected to reach USD 4.88 billion by 2030, expanding at a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for medicines that address iodine deficiency in the thyroid gland is a key driver for the market. In addition, the requirement for enriched animal feed is also boosting product demand.
Based on segmentation by source, iodine is derived from caliche ore, underground brines, recycling, and seaweed. Caliche ore accounted for the largest revenue share in 2023 due to its widespread availability in the earth's crust. The two naturally occurring crystalline forms of iodine in caliche ore are lautarite and dietzeite, constituting around 0.04% (400 ppm) of iodine.
Based on data from the World Iodine Association, about 2 billion people around the globe are afflicted by iodine deficiency, which is understood to be one of the most preventable causes of mental retardation in children and adults. It also results in decreased rates of metabolism, thereby impacting the general functioning and efficiency of people.
The global iodine industry is highly concentrated. The growth in the medical devices and pharmaceutical industry are the key market drivers. For instance, in May 2023 , GE Healthcare announced that it would expand its active pharmaceutical ingredient (API) manufacturing capacity in Lindesnes, Norway for an investment of USD 80 million. This would increase its production capacity by 30% at this site. This was following an agreement it signed in October 2022 with Sociedad Quimica y Minera de Chile S.A, for securing iodine supply for its Pharmaceutical Diagnostics business. In medical devices such as X-ray and Computed Tomography (CT) procedures, iodine continues to be a key ingredient for contrast media products.